Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Chlorpheniramine maleate Market Price & Analysis > Market Insights - Chlorpheniramine maleate > Jiangsu Lianhuan Pharmaceutical Co., Ltd. builds 13 API projects including anti-diabetic (LH-1801) innovative drugs, chlorpheniramine maleate, and milrinone
— Share —

Jiangsu Lianhuan Pharmaceutical Co., Ltd. builds 13 API projects including anti-diabetic (LH-1801) innovative drugs, chlorpheniramine maleate, and milrinone

healthoo 2021-05-19
Announcement on the environmental impact assessment documents of Jiangsu Lianhuan Pharmaceutical Co., Ltd.'s anti-diabetic (LH-1801) and other generic drugs such as milrinone and other generic drug production lines and supporting facilities

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.